Sample, data use and protection in biobanking in Europe: Legal issues

Pharmacogenomics

Volumn 9, Issue 6, 2008, Pages 773-781

  Zika, Eleni ^a   in den Bäumen, Tobias Schulte ^b   Kaye, Jane ^c   Brand, Angela ^b   Ibarreta, Dolores ^a  

^a JOINT RESEARCH CENTRE   (Italy)

^b German Center for Public Health Genomics   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anonymization; Biobanks; Consent; Data protection; Ethics committees; European Data Protection Directive; Harmonization; Networking; Sample sharing; Sample storage

Indexed keywords

ACCESS TO INFORMATION; ANONYMOUS TESTING; ARTICLE; CANCER REGISTRY; COMPUTER PROGRAM; DONOR; EUROPE; FINANCIAL MANAGEMENT; GENETIC ANALYSIS; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HUMAN; HUMAN RIGHTS; INFORMATION DISSEMINATION; INFORMATION PROCESSING; INFORMED CONSENT; LAW; MATERIALS HANDLING; MEDICAL EXPERT; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; PATIENT AUTONOMY; PATIENT SAFETY; PHARMACOGENETICS; PHARMACOGENOMICS; PRACTICE GUIDELINE; PRIVACY; RESEARCH ETHICS; SPAIN; WORKSHOP; CONFIDENTIALITY; ETHICS; GENETIC DATABASE; GENETICS; GOVERNMENT REGULATION; LEGAL ASPECT;

BIOLOGICAL SPECIMEN BANKS; CONFIDENTIALITY; DATABASES, GENETIC; EUROPE; GENETIC RESEARCH; GOVERNMENT REGULATION;

EID: 48949119309     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.6.773     Document Type: Article

References (9)

1. Brand A, Brand H: Public health genomics - Relevance for individual health information management, health policy development and effective health services. Ital. J. Public Health 3(3-4), 24-34 (2006).
2. Zika E, Gurwitz D, Ibarreta D: Pharmacogenetics and pharmacogenomics: state-of-the-art and potential socioeconomic impact in the EU. European Commission DG JRC/IPTS, EUR 22214 (2006).
3. Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. Official Journal L. 281, 31-50 (1995).
4. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
5. Yuille M, van Ommen GJ, Bréchot C et al.: Biobanking for Europe. Brief Bioinformatics 9(1), 14-24 (2008).
6. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM: Trends in ethical and legal frameworks for the use of human biobanks. Eur. Respir. J. 30(2), 373-382 (2007).
7. Eriksson S: Informed consent and biobanks. In: The use of human biobanks: ethical social. economical, and legal aspects. Harisson MG (Ed.). Uppsala, Uppsala, University, Sweden, 41-51 (2001).
8. Knoppers BM, Saginur M: The babel of genetic data terminology. Nat. Biotech. 23, 925-927 (2005).
9. Reischl I, Schroder M. Luttenberger N. Petrov S et al.: Pharmacogenetics research and data protection - challenges and solutions. Pharmacogenomics J. 6, 225-233 (2006).